Olympiad Research’s Humana HUM Stock Holding History

Olympiad Research’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-489	Closed	-$202K	–	229
2020 Q3	$202K	Buy	+489	New	+$197K	0.1%	285

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Olympiad Research's HUM Position: Q4 2020 in Review

Olympiad Research sold out of Humana (HUM) in Q4 2020, closing a stake of 489 shares — an estimated $202K sold.

Olympiad Research first reported a position in HUM in Q3 2020 and held it in 1 quarter. The position peaked at $202K in Q3 2020. 867 funds tracked by Wall St. Rank hold HUM as of Q4 2020.

Olympiad Research reported no remaining Humana position as of Q4 2020 after selling out during the quarter.
Olympiad Research sold 489 Humana shares in Q4 2020, an estimated $202K.
Olympiad Research first reported a position in Humana in Q3 2020 and held it in 1 quarter.
Olympiad Research's Humana position peaked at $202K in Q3 2020.
867 funds tracked by Wall St. Rank held Humana as of Q4 2020.

Based on Olympiad Research's 13F filing for Q4 2020, filed 5 Feb 2021.